Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$24.99

Current Ratio
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Abbott Laboratories, current ratio, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions


The analysis of the annual financial data reveals fluctuations and trends in the company's liquidity position over the evaluated period.

Current Assets
Current assets demonstrated an overall increasing trend from 2005 through 2012, rising from 11,386 million US$ to a peak of 31,323 million US$. A notable decline followed in 2013 and 2014, reaching 15,261 million US$ in 2014. Subsequently, there was a significant surge in 2016 up to 26,776 million US$, before declining and fluctuating in the years after. The levels stabilized around the 22,000 to 25,000 million US$ range during 2021-2024.
Current Liabilities
Current liabilities peaked in 2006 at 11,951 million US$ but generally fluctuated around 9,000 to 13,000 million US$ in subsequent years until a marked drop to 6,660 million US$ in 2016. Following this low, current liabilities increased again, reaching 15,489 million US$ in 2022 before slightly decreasing towards 14,157 million US$ in 2024. This pattern reflects significant variability, with no clear long-term upward or downward trend.
Current Ratio
The current ratio exhibited considerable volatility. It decreased sharply from 1.54 in 2005 to 0.94 in 2006, indicating a drop in liquidity. The ratio recovered thereafter, peaking at 4.02 in 2016, driven by the combination of high current assets and low current liabilities. Post-2016, the ratio declined and stabilized around the 1.6 – 1.85 range, signaling a moderate liquidity position maintained more consistently through the later years.

Overall, the data shows the company managed its liquidity with varying success over the years, experiencing periods of both strong liquidity and tighter working capital conditions. The exceptional current ratio in 2016 may suggest one-time circumstances impacting asset and liability levels, while the stabilization in recent years indicates a more balanced approach to managing short-term financial obligations.


Comparison to Competitors

Abbott Laboratories, current ratio, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

Abbott Laboratories, current ratio, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)